We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+16.3%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$36.7B
AUM Growth
+$4.73B
Cap. Flow
+$3.45B
Cap. Flow %
9.42%
Top 10 Hldgs %
15.54%
Holding
3,403
New
385
Increased
1,787
Reduced
944
Closed
189

Sector Composition

Rank Sector Weight
1 Healthcare 9.66%
2 Technology 9.09%
3 Financials 7.96%
4 Consumer Staples 7.25%
5 Industrials 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPD icon
76
Enterprise Products Partners
EPD
$82B
$92M 0.25%
3,329,625
+889,058
+36% +$24.6M
PPL
77
PPL Corp
PPL
$26B
$91.9M 0.25%
2,658,921
+217,225
+9% +$7.82M
ETN icon
78
Eaton
ETN
$175B
$91.3M 0.25%
1,389,504
+164,901
+13% +$10.7M
TEL icon
79
TE Connectivity
TEL
$62.9B
$90.5M 0.25%
1,405,911
+101,483
+8% +$6.21M
CB icon
80
Chubb
CB
$136B
$90.4M 0.25%
719,439
+86,484
+14% +$11M
D icon
81
Dominion Energy
D
$58.6B
$90.3M 0.25%
1,215,935
+307,422
+34% +$23.4M
JNK icon
82
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.91B
$90M 0.25%
816,583
+113,379
+16% +$12.3M
AMGN icon
83
Amgen
AMGN
$218B
$89.4M 0.24%
536,099
+131,566
+33% +$22.2M
RSP icon
84
Invesco S&P 500 Equal Weight ETF
RSP
$98.7B
$89.2M 0.24%
1,067,099
-80,911
-7% -$6.73M
AGN
85
DELISTED
Allergan plc
AGN
$89M 0.24%
386,233
+28,153
+8% +$6.88M
IRM icon
86
Iron Mountain
IRM
$36.3B
$88.6M 0.24%
2,361,905
-53,912
-2% -$2.08M
DIS icon
87
Walt Disney
DIS
$180B
$88.3M 0.24%
951,204
+144,224
+18% +$13.8M
AZN icon
88
AstraZeneca
AZN
$248B
$87.7M 0.24%
1,334,559
+703,651
+112% +$46M
BIIB icon
89
Biogen
BIIB
$30.2B
$87.7M 0.24%
280,108
+32,791
+13% +$9.71M
MCHP icon
90
Microchip Technology
MCHP
$42.5B
$87.7M 0.24%
2,821,014
+94,428
+3% +$2.75M
AVGO icon
91
Broadcom
AVGO
$2.02T
$87.4M 0.24%
5,067,140
+103,940
+2% +$1.74M
CAH icon
92
Cardinal Health
CAH
$55.2B
$85.9M 0.23%
1,106,021
+170,142
+18% +$13.8M
BND icon
93
Vanguard Total Bond Market
BND
$157B
$84.7M 0.23%
1,006,530
+140,339
+16% +$11.8M
CVS icon
94
CVS Health
CVS
$123B
$83.5M 0.23%
938,382
-3,616
-0.4% -$341K
VTR icon
95
Ventas
VTR
$47.2B
$82.9M 0.23%
1,174,233
+99,298
+9% +$7.21M
USB icon
96
US Bancorp
USB
$99.5B
$82.8M 0.23%
1,929,926
+298,879
+18% +$12.7M
ORCL icon
97
Oracle
ORCL
$416B
$82.2M 0.22%
2,092,256
+572,710
+38% +$23.3M
SJNK icon
98
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.75B
$81.3M 0.22%
2,937,517
-330,233
-10% -$9.03M
TTE icon
99
TotalEnergies
TTE
$191B
$80.6M 0.22%
13,638,347,653
-877,020,381,266
-98% -$614M
APC
100
DELISTED
Anadarko Petroleum
APC
$80.4M 0.22%
1,269,257
-97,123
-7% -$5.41M

Similar funds

Raymond James & Associates's Q3 2016 Portfolio in Review

As of Q3 2016, Raymond James & Associates held 3,403 positions worth $36.7B, up 15% from $31.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $3.45B of net new capital in Q3 2016, opening 385 new positions and adding to 1,787 existing holdings. Its largest new stake was iShares MSCI India Small-Cap ETF: 414,364 shares worth $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, up from 9.6% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was TotalEnergies, an estimated $614M trimmed.

  • Raymond James & Associates's largest Q3 2016 buy was iShares MSCI India Small-Cap ETF: 414,364 shares worth $15.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2016, an estimated $196M increase.
  • Raymond James & Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $614M.
  • Raymond James & Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $61.1M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $36.7B portfolio in Q3 2016.
  • Raymond James & Associates opened 385 new positions and closed 189 in Q3 2016.
  • Raymond James & Associates's portfolio value rose 15% quarter-over-quarter to $36.7B.

Based on Raymond James & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.